{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:47:28Z","timestamp":1786992448926,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ginseng Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jgr.2026.100988","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:27:36Z","timestamp":1769819256000},"page":"100988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ginsenoside Rg1 ameliorates experimental autoimmune myasthenia gravis by regulating T cell subsets, inhibiting PI3K-AKT pathway and modulating gut microbiota and metabolites"],"prefix":"10.1016","volume":"50","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-nan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-lin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4385-3591","authenticated-orcid":false,"given":"Yan-bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jgr.2026.100988_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jgr.2026.100988_bib2","article-title":"Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study","volume":"5","author":"Chen","year":"2020","journal-title":"Lancet Reg Health West Pac"},{"issue":"5","key":"10.1016\/j.jgr.2026.100988_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/WCO.0000000000001196","article-title":"Current drug treatment of myasthenia gravis","volume":"36","author":"Vanoli","year":"2023","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"10.1016\/j.jgr.2026.100988_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/CND.0000000000000257","article-title":"Impact of refractory Myasthenia gravis on health-related quality of life","volume":"20","author":"Boscoe","year":"2019","journal-title":"J Clin Neuromuscul Dis"},{"issue":"3","key":"10.1016\/j.jgr.2026.100988_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of Myasthenia Gravis: 2020 update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jgr.2026.100988_bib6","first-page":"551","article-title":"[Myasthenia gravis: current status of antibody diagnostics and aspects on refractory myasthenia gravis]","volume":"86","author":"Wenninger","year":"2018","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"5","key":"10.1016\/j.jgr.2026.100988_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/WCO.0000000000000596","article-title":"Myasthenia gravis: from autoantibodies to therapy","volume":"31","author":"Mantegazza","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jgr.2026.100988_bib8","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.924393","article-title":"AEB-071 ameliorates muscle weakness by altering helper T lymphocytes in an experimental autoimmune myasthenia gravis rat model","volume":"26","author":"Jing","year":"2020","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.jgr.2026.100988_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/acn3.51312","article-title":"In\u2010depth peripheral CD4+ T profile correlates with myasthenic crisis","volume":"8","author":"Huan","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jgr.2026.100988_bib10","first-page":"1","article-title":"Defects of CTLA-4 are associated with regulatory T cells in Myasthenia gravis implicated by intravenous immunoglobulin therapy","volume":"2020","author":"Xu","year":"2020","journal-title":"Mediat Inflamm"},{"issue":"3","key":"10.1016\/j.jgr.2026.100988_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgr.2026.100988_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01127","article-title":"The kinase complex mTOR complex 2 promotes the follicular migration and functional maturation of differentiated follicular helper CD4+ T cells during viral infection","volume":"9","author":"Hao","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jgr.2026.100988_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000945","article-title":"Immune skew of circulating follicular helper T cells associates with Myasthenia gravis severity","volume":"8","author":"Ashida","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.jgr.2026.100988_bib14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1084\/jem.20080034","article-title":"In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ ROR\u03b3t+ T cells","volume":"205","author":"Lochner","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jgr.2026.100988_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12974-015-0334-4","article-title":"Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway","volume":"12","author":"Wang","year":"2015","journal-title":"J Neuroinflammation"},{"issue":"12","key":"10.1016\/j.jgr.2026.100988_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrneurol.2017.142","article-title":"Multiple sclerosis: a possible link between multiple sclerosis and gut microbiota","volume":"13","author":"Hindson","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jgr.2026.100988_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02949","article-title":"Therapeutic effect of bifidobacterium administration on experimental autoimmune myasthenia gravis in lewis rats","volume":"10","author":"Rinaldi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jgr.2026.100988_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00639","article-title":"The Treg\/Th17 axis: a dynamic balance regulated by the gut microbiome","volume":"6","author":"Omenetti","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jgr.2026.100988_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/nyas.13567","article-title":"Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis?","volume":"1413","author":"Rinaldi","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jgr.2026.100988_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803101","article-title":"Gut microbiota as regulators of Th17\/Treg balance in patients with Myasthenia Gravis","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jgr.2026.100988_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.564579","article-title":"Differential gut microbiota and fecal metabolites related with the clinical subtypes of Myasthenia gravis","volume":"11","author":"Tan","year":"2020","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jgr.2026.100988_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-021-02034-0","article-title":"Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis","volume":"19","author":"Liu","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.jgr.2026.100988_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106805","article-title":"Ginsenoside Rg1 prevent and treat inflammatory diseases: a review","volume":"87","author":"Gao","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jgr.2026.100988_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.817600","article-title":"Ginsenoside Rg1 alleviates acute ulcerative colitis by modulating gut microbiota and microbial tryptophan metabolism","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jgr.2026.100988_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108133","article-title":"Ginsenoside Rg1 relieves experimental colitis by regulating balanced differentiation of Tfh\/Treg cells","volume":"100","author":"Jin","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.jgr.2026.100988_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14053","article-title":"Ginsenoside Rg1 ameliorates psoriasis\u2010like skin lesions by suppressing proliferation and NLRP3 inflammasomes in keratinocytes","volume":"46","author":"Mao","year":"2022","journal-title":"J Food Biochem"},{"key":"10.1016\/j.jgr.2026.100988_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.817600","article-title":"Ginsenoside Rg1 alleviates acute ulcerative colitis by modulating gut Microbiota and microbial Tryptophan metabolism","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jgr.2026.100988_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/WNR.0000000000001891","article-title":"Ginsenoside Rg1 attenuation of neurogenesis disorder and neuronal apoptosis in the rat hippocampus after spinal cord injury may involve brain-derived neurotrophic factor\/extracellular signal-regulated kinase signaling","volume":"34","author":"XI","year":"2023","journal-title":"Neuroreport"},{"key":"10.1016\/j.jgr.2026.100988_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175431","article-title":"Ginsenoside-Rg1 mitigates cardiac arrest-induced cognitive damage by modulating neuroinflammation and hippocampal plasticity","volume":"938","author":"Wu","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jgr.2026.100988_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/0471250953.bi0814s24","article-title":"Using AutoDock for ligand-receptor docking","author":"Morris","year":"2008","journal-title":"Curr Protoc Bioinform"},{"key":"10.1016\/j.jgr.2026.100988_bib31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2019.05.006","article-title":"Inhibition of ROCK activity regulates the balance of Th1, Th17 and Treg cells in myasthenia gravis","volume":"203","author":"Song","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jgr.2026.100988_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132129","article-title":"A targeted and nontargeted metabolomics study on the oral processing of epicatechins from green tea","volume":"378","author":"Cao","year":"2022","journal-title":"Food Chem"},{"issue":"4","key":"10.1016\/j.jgr.2026.100988_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/08830185.2019.1632842","article-title":"Synergy between Th1 and Th2 responses duringMycobacterium tuberculosisinfection: a review of current understanding","volume":"38","author":"Abebe","year":"2019","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.jgr.2026.100988_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2018.11.005","article-title":"Il-23\/Th17 cell pathway: a promising target to alleviate thymic inflammation maintenance in myasthenia gravis","volume":"98","author":"Villegas","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jgr.2026.100988_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.06.011","article-title":"Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients","volume":"78","author":"Xie","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jgr.2026.100988_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cyto.2017.05.008","article-title":"Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity","volume":"96","author":"Aguilo-Seara","year":"2017","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.jgr.2026.100988_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jgr.2026.100988_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01785","article-title":"Immunopathogenesis in Myasthenia gravis and Neuromyelitis Optica","volume":"8","author":"Wang","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jgr.2026.100988_bib39","article-title":"Effects of mitophagy on regulatory T cell function in patients with Myasthenia gravis","volume":"11","author":"Wang","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.jgr.2026.100988_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01510","article-title":"T follicular helper cells as a new target for immunosuppressive therapies","volume":"8","author":"Yan","year":"2017","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.jgr.2026.100988_bib41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2174\/1566524019666190827162615","article-title":"Effects of follicular helper T cells and inflammatory cytokines on Myasthenia gravis","volume":"19","author":"Wang","year":"2019","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jgr.2026.100988_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mcn.2013.12.006","article-title":"RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice","volume":"58","author":"Xin","year":"2014","journal-title":"Mol Cell Neurosci"},{"issue":"5357","key":"10.1016\/j.jgr.2026.100988_bib43","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1126\/science.279.5357.1737","article-title":"Recognition of stress-induced MHC molecules by intestinal epithelial \u03b3\u03b4 T cells","volume":"279","author":"Groh","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jgr.2026.100988_bib44","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/eji.1830230405","article-title":"Peripheral selection of antigen receptor junctional features in a major human gamma delta subset","volume":"23","author":"Davodeau","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jgr.2026.100988_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108793","article-title":"Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis","volume":"230","author":"Liu","year":"2021","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.jgr.2026.100988_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/ar1470","article-title":"Increased interleukin-17 production via a phosphoinositide 3-kinase\/Akt and nuclear factor \u03baB-dependent pathway in patients with rheumatoid arthritis","volume":"7","author":"Kim","year":"2004","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.jgr.2026.100988_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2012.06.316","article-title":"IL-22 induced cell proliferation is regulated by PI3K\/Akt\/mTOR signaling cascade","volume":"60","author":"Mitra","year":"2012","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.jgr.2026.100988_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1308-y","article-title":"Increased serum concentrations of IL-1 beta, IL-21 and Th17 cells in overweight patients with rheumatoid arthritis","volume":"19","author":"Shoda","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.jgr.2026.100988_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71998-9","article-title":"Author Correction: the protective effect of ginsenoside Rg1 against sepsis-induced lung injury through PI3K-Akt pathway: insights from molecular dynamics simulation and experimental validation","volume":"14","author":"Zhong","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgr.2026.100988_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.02627","article-title":"Altered gut Microbiota in Myasthenia Gravis","volume":"9","author":"Qiu","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgr.2026.100988_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211035657","article-title":"Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study","volume":"14","author":"Totzeck","year":"2021","journal-title":"Therapeut Adv Neurol Disord"},{"issue":"10","key":"10.1016\/j.jgr.2026.100988_bib52","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/nu3100858","article-title":"Regulation of inflammation by short chain fatty acids","volume":"3","author":"Vinolo","year":"2011","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jgr.2026.100988_bib53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10753-019-01133-8","article-title":"The anti-inflammatory immune regulation induced by butyrate is impaired in inflamed intestinal mucosa from patients with ulcerative colitis","volume":"43","author":"Magnusson","year":"2019","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.jgr.2026.100988_bib54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3920\/BM2020.0057","article-title":"Short chain fatty acids in human gut and metabolic health","volume":"11","author":"Blaak","year":"2020","journal-title":"Benef Microbes"},{"issue":"8","key":"10.1016\/j.jgr.2026.100988_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/nu14081647","article-title":"Exploring the gut microbiome in Myasthenia Gravis","volume":"14","author":"Thye","year":"2022","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.jgr.2026.100988_bib56","article-title":"Prophylactic effect of probiotics on the development of experimental autoimmune Myasthenia Gravis","volume":"7","author":"Platten","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jgr.2026.100988_bib57","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/neurolint15010026","article-title":"The role of human microbiota in Myasthenia Gravis: a narrative review","volume":"15","author":"Schir\u00f2","year":"2023","journal-title":"Neurol Int"}],"container-title":["Journal of Ginseng Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S122684532600014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S122684532600014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:28:33Z","timestamp":1777876113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S122684532600014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S122684532600014X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgr.2026.100988","relation":{},"ISSN":["1226-8453"],"issn-type":[{"value":"1226-8453","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenoside Rg1 ameliorates experimental autoimmune myasthenia gravis by regulating T cell subsets, inhibiting PI3K-AKT pathway and modulating gut microbiota and metabolites","name":"articletitle","label":"Article Title"},{"value":"Journal of Ginseng Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgr.2026.100988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Korean Society of Ginseng. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100988"}}